NCT07215611

Brief Summary

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
54mo left

Started Sep 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Sep 2025Oct 2030

Study Start

First participant enrolled

September 2, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 9, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 10, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2030

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

October 9, 2025

Last Update Submit

April 28, 2026

Conditions

Bone SarcomasFinancial Toxicity

Outcome Measures

Primary Outcomes (1)

  • Questionnaires

    Through study completion; an average of 1 year

Interventions

data collectionOTHER

data collection from electronic health records

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

You may qualify if:

  • Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
  • Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.

You may not qualify if:

  • Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Bone NeoplasmsFinancial Stress

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBone DiseasesMusculoskeletal DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Shalin S Patel, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shalin S Patel, MD

CONTACT

713-792-6268sspatel@mdanderson.org

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2025

First Posted

October 10, 2025

Study Start

September 2, 2025

Primary Completion (Estimated)

October 2, 2028

Study Completion (Estimated)

October 2, 2030

Last Updated

April 30, 2026

Record last verified: 2026-04

Locations

US(1)